12 results
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... very tolerable medication ... #Pharmacology # ... Management #Diabetes #DM2 ... #Endocrinology
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
and sodium • Dosing ... QD (adjust dose ... #Hyperkalemia #medications ... #pharmacology # ... table #comparison
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Diabetes #Mellitus #DM2 ... #pharmacology # ... comparison #table ... #endocrinology
Pearls for Treatment of Alcohol Use Disorder

First-line pharmacotherapies for moderate to severe AUD include naltrexone and
actively using ... respectively) at the doses ... psychaedelics #Alcohol #UseDisorder ... Screening #Addiction #Medications ... #Pharmacology
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
e.g. at lower doses ... #pharmacology #comparison ... #treatment #medications ... #dosing #drugs ... #table #pharmacotherapy
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
commonly used medications ... mistaken these medications ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes ... #DM2 #Endocrinology
Inpatient Management of Opioid Use Disorder: Methadone vs Buprenorphine - Comparison Table

Some patients may decline buprenorphine
Buprenorphine - Comparison Table ... interested in medication ... Dosing usually begins ... formulation, the dose ... Management #Opioid #UseDisorder
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... semaglutide, the same medication ... drug to remain stable ... semaglutide #Diabetes #Pharmacology ... #Endocrinology
Opioid Use Disorder Medications - Pharmacokinetics

Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
in which higher doses ... the sublingual tablet ... #Opioid #UseDisorder ... #Comparison #Table ... #Pharmacology #
Insulin Calculations for Type 1 Diabetes 

Insulin-to-Carb Ratio (ICR) 500/TDD = #g of carbs covered by
ICR) 500/TDD = #g ... calculations used in dosing ... Type1 #Diabetes #DM1 ... #Pharmacology # ... Endocrinology